Clinical Significance of Aortic Root Modification Associated With Bicuspid Aortic Valve in Marfan Syndrome.

Archive ouverte

Milleron, Olivier | Ropers, Jacques | Arnoult, Florence | Bouleti, Claire | Delorme, Gabriel | Langeois, Maud | Tchitchinadze, Maria | Guien, Celine | Béroud, Christophe | Boileau, Catherine | Jondeau, Guillaume

Edité par CCSD ; American Heart Association -

International audience. BACKGROUND:Both bicuspid aortic valve (BAV) and Marfan syndrome have been associated with aortic dissection risk, but it is unknown whether the presence of BAV is associated with an increased aortic risk in patients with an FBN1 gene mutation. We evaluated aortic diameters, aortic valve function, and aortic shape in Marfan syndrome patients with and without BAV and reported aortic events during follow-up.METHODS:All patients with an FBN1 gene mutation evaluated in our clinic were included. Aortic root diameters were measured, and the aortic valve was studied using echocardiography at each visit.RESULTS:Of the 1437 patients with an FBN1 gene mutation, 26 patients (1.8%) had a BAV. Both aortic root maximal diameter and normalized Z score were larger at all ages, in patients with BAV when compared with patients with tricuspid aortic valve. Prophylactic aortic root surgery tended to be performed in younger patients when BAV was present, although aortic diameter threshold was similar in the 2 populations. No aortic dissection was observed in Marfan syndrome patients with BAV.CONCLUSIONS:In patients with a FBN1 mutation, BAV is associated with larger aortic root diameter, with no difference in evolution of Z score with age. We found a trend towards prophylactic aortic root surgery at younger ages but similar aortic diameter thresholds without occurrence of aortic dissection. We did not find any evidence for lowering aortic diameter thresholds used to propose preventive aortic root surgery in the presence of BAV in patients with FBN1 mutations.

Consulter en ligne

Suggestions

Du même auteur

Pathogenic FBN1 Genetic Variation and Aortic Dissection in Patients With Marfan Syndrome

Archive ouverte | Milleron, Olivier | CCSD

International audience. BackgroundAortic risk has not been evaluated in patients with Marfan syndrome and documented pathogenic variants in the FBN1 gene.ObjectivesThis study sought to describe aortic risk in a popu...

Genetic diversity and pathogenic variants as possible predictors of severity in a French sample of nonsyndromic heritable thoracic aortic aneurysms and dissections (nshTAAD)

Archive ouverte | Arnaud, Pauline | CCSD

International audience. Purpose : Heritable thoracic aortic aneurysms and dissections (hTAAD) are life-threatening complications of well-known syndromic diseases or underdiagnosed nonsyndromic heritable forms (nshTA...

Marfan Sartan: a randomized, double-blind, placebo-controlled trial

Archive ouverte | Milleron, Olivier | CCSD

International audience. Aims - To evaluate the benefit of adding Losartan to baseline therapy in patients with Marfan syndrome (MFS). Methods and results - A double-blind, randomized, multi-centre, placebo-controll...

Chargement des enrichissements...